James Heyward

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Drug Administration

Top Venues

Annals of internal medicine

Pharmaceutical statistics

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Jodi B Segal, Ravi Varadhan, Rolf H H Groenwold, Xiaojuan Li, Kaori Nomura, Sigal Kaplan, Shirin Ardeshir-Rouhani-Fard, James Heyward, Fredrik Nyberg, Mehmet Burcu
Assessing Heterogeneity of Treatment Effect in Real-World Data. Annals of internal medicine (2023)
Jodi B Segal, Ravi Varadhan, Rolf H H Groenwold, Xiaojuan Li, Kaori Nomura, Sigal Kaplan, Shirin Ardeshir-Rouhani-Fard, James Heyward, Fredrik Nyberg, Mehmet Burcu
Assessing Heterogeneity of Treatment Effect in Real-World Data. Annals of internal medicine (2023)
James Heyward, Milena Lolic, Catherine Spong, David Atkins, Gene Pennello, Ravi Varadhan
Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Keynote and panel discussion on communicating heterogeneous treatment effects across populations. Pharmaceutical statistics 20 (5) (2021)
James Heyward, Jacob Christopher, Sudipa Sarkar, Jung-Im Shin, Rita R Kalyani, G Caleb Alexander
Ambulatory noninsulin treatment of type 2 diabetes mellitus in the United States, 2015 to 2019. Diabetes, obesity & metabolism 23 (8) (2021)
Omar Mansour, Matthew Tajanlangit, James Heyward, Ramin Mojtabai, G Caleb Alexander
Telemedicine and Office-Based Care for Behavioral and Psychiatric Conditions During the COVID-19 Pandemic in the United States. Annals of internal medicine 174 (3) (2020)
James Heyward, Thomas J Moore, Jennifer Chen, Kristin Meek, Peter Lurie, G Caleb Alexander
Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018. Annals of internal medicine 173 (12) (2020)